Anxiety Levels Amid the COVID-19 Lockdown in Saudi Arabia

Int J Gen Med. 2021 May 31:14:2161-2170. doi: 10.2147/IJGM.S312465. eCollection 2021.

Abstract

Objective: To assess the prevalence of anxiety and factors associated with it during the peak of the outbreak in Saudi Arabia.

Materials and methods: This cross-sectional research screened the general public using the Generalized Anxiety Disorder Scale-7 to detect anxiety levels. The questionnaire was distributed online during May 2020, while lockdowns were enforced. A total of 3017 respondents from all five main regions of Saudi Arabia completed the survey. The prevalence of anxiety was measured. Chi-square and logistic regression analyses were executed to determine associated factors with anxiety during peak lockdown.

Results: About 19.6% of the respondents possessed a moderate to severe level of anxiety during the pandemic. Western, Northern, and Eastern regions of Saudi Arabia were found to be the most anxious. Female participants had 5.3% higher levels of anxiety compared to male counterparts. The youngest age group (18 to 19 years), most of them were students, reported the highest frequency of anxiety (28.7%). Divorced and single participants had a higher level of anxiety compared to married ones. After adjusted with other variables, living with a family member with risk of the COVID-19 was the best predictor assessing anxiety amid peak lockdown (OR: 1.8, 95% CI: 1.4-2.2).

Conclusion: Notable anxiety prevailed during the initial phase of the COVID-19 outbreak in Saudi Arabia. The presence of vulnerable subjects in the family augments this psychological disorder considerably. Our findings promulgate a need to inculcate nation-wide strategies to enforce public health emergency preparedness plans to mitigate the adverse psychological effects of outbreaks.

Keywords: COVID-19; Saudi Arabia; anxiety disorder; prevalence; psychological impact.

Grants and funding

Funding: This work was supported by the Imam Abdulrahman Bin Faisal University COVID-19 fund [grant number Covid19-2020-024-CAMS].